Antacids directly target the excess acids and get rid of them unlike other medications which reduce or prevent stomach acid excretion. Hence it shows better results compared to other medications

Hyderabad, India -- (SBWire) -- 01/29/2018 --The report "Antacid Market by submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Healthcare IT outsourcing, Clinical Trial Management Systems(CTMS), Immunoassay, Digital Pathology, Next Generation sequencing(NGS), Proteomics, Antacids with Antiflatulents), Application (Novel dietary fibers), Ingredients (Protease, Modified starch, Food & Beverage Starch, Gelatin, Collagen, Carbohydrase, Food & Beverage Sugars & its substitutes) - Forecast to 2021", The Antacid market is expected to reach USD 5.88 Billion by 2021 from an estimated USD 3.88 Billion in 2016, at a CAGR of 2.5%. The key factors such as better formulation, route of administration growing demand for personalized medicine are driving the growth of this market.

Browse through 175 Pages and in-depth TOC on "Antacid Market "
https://www.marketdataforecast.com/market-reports/global-antacid-market-2360/
Early buyers will receive 10% customization on reports.

By submarkets, Chromatography accounted for the largest share of the market in 2016.

On the basis of submarkets such as Chromatography, E-Clinical Trial Solutions, Wireless Health, Healthcare IT outsourcing, Clinical Trial Management Systems(CTMS), Immunoassay, Digital Pathology, Next Generation sequencing(NGS), Proteomics, Antacids with Antiflatulents.
By Application, Novel dietary fibers accounted for the largest share of the market in 2016

Customized Report: https://www.marketdataforecast.com/market-reports/global-antacid-market-2360/customize-report

On the basis of Ingredients, the Antacid market has been segmented Protease, Modified starch, Food & Beverage Starch, Gelatin, Collagen, Carbohydrase, Food & Beverage Sugars & its substitutes. It is also expected to be the fastest-growing segment during the forecast period..

Inquire: https://www.marketdataforecast.com/market-reports/global-antacid-market-2360/request-sample

North America accounted for the largest share of the Antacid market in 2016, followed by Europe. The large share of the North American Antacid market can be attributed to the growth in biotechnology and Antacid research grants and funds in the US.

The various players in the Antacid market include First Aid Only, WellSpring Pharm, GSK, Private Lable, Pfizer, Procter & Gamble, Glaxosmithkline, Boehringer Ingellheim Pharm, Novaritis Consurmer Health, Johnson & Johnson among others.

About MarketDataForecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626